DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pioglitazone Hydrochloride And Metformin Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Macleods Pharms Ltd, Mylan, Sandoz, Teva Pharms Usa, and Torrent Pharms Ltd. and is included in six NDAs.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
Recent Clinical Trials for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|All India Institute of Medical Sciences, Bhubaneswar||Phase 4|
|Azienda Ospedaliero-Universitaria di Parma||Phase 2/Phase 3|
|Chang Gung Memorial Hospital||Phase 2|